Genvira Biosciences at the Ottawa Hospital Research Institute specializes in designing, constructing and characterizing customized DNA and RNA viruses for gene therapy, vaccination and cancer immunotherapy. We have extensive experience in engineering both pre-clinical and clinical grade products, leading up to IND applications and clinical trials. Our mission is to provide high quality viral vectors in a timely and cost-effective manner for the scientific community.

A unique advantage for Genvira’s service is that vectors engineered can be transferred seamlessly to the Ottawa Hospital Research Institute’s viral manufacturing facility for GMP-quality production, providing our clients an end-to-end solution to quickly bring novel biologics to clinics.